Marksans Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
724.98
709.70
652.98
605.57
576.54
Other Income Qtr Cr16.5227.8511.0614.9516.53
Operating Revenues Qtr708.46681.85641.92590.62560.01

*All values are in Cr.

Operating Expenses Qtr
582.70
543.08
506.24
462.18
450.37
Operating Profit Qtr
125.75
138.76
135.68
128.44
109.64
EBITDA Qtr Cr
142.27
166.61
146.74
143.38
126.17
Depreciation Qtr
22.74
20.69
19.51
20.44
21.06
Net Profit Qtr
90.55
104.56
96.72
88.75
78.29
Basic EPS Qtr
2.00
2.31
2.13
1.96
1.73
Open Demat Account
+91 -

Open Demat Account
+91 -